The Supreme Court is set to hear oral arguments in a case that could impact how mifepristone is used in the U.S. The case involves the FDA's changes to safety restrictions for mifepristone, including allowing mail delivery and telemedicine prescriptions. The Alliance Defending Freedom filed a lawsuit against the FDA, alleging safety concerns. The case challenges FDA actions since the approval of mifepristone in 2000.
Key Points
Impact of FDA's safety restrictions on mifepristone use
Lawsuit filed by the Alliance Defending Freedom against the FDA
Challenges to FDA actions since the approval of mifepristone
Pros
Potential for increased access to medication abortion for women
Flexibility in how mifepristone is prescribed and obtained
Cons
Safety concerns raised by opponents of the FDA's changes
Legal challenges regarding the legality of FDA actions